English

QUESTCOR PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2014-07-25

95 filing records in this dataset, filed from 1996-06-12 to 2014-07-25. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

279 million USD

2014 Q2 · USD

Exact inputs and evidence

Revenue: 278830000 USD Source

Operating margin

52.99%

2014 Q2 · %

Exact inputs and evidence

Operating Income: 147764000 USD Source
Revenue: 278830000 USD Source

Operating cash flow

99.4 million USD

2014 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 205431000 USD Source
Operating Cash Flow: 106074000 USD Source

Free cash flow

93.3 million USD

2014 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 205431000 USD Source
Operating Cash Flow: 106074000 USD Source
Capital Expenditure: 8266000 USD Source
Capital Expenditure: 2252000 USD Source

Cash and cash equivalents: 332 million USD 2014-06-30 Source
Exact value

331679000 USD
Long-term debt including current maturities: 15.7 million USD 2013-12-31 Source
Exact value

15663000 USD
Shares outstanding: 61.4 million shares 2014-06-30 Source
Exact value

61448937 shares

Reported share-count change

2.43% · 1.46 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

59993867 shares · 2013-06-30· Source
61448937 shares · 2014-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-07-25.

Financial data available through: 2013-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2013-12-31
Operating income: 10 of 11 periods available· newest 2013-12-31
Net income: 10 of 11 periods available· newest 2013-12-31
Operating cash flow: 10 of 11 periods available· newest 2013-12-31
Capital expenditure: 10 of 11 periods available· newest 2013-12-31
Total assets: 10 of 11 periods available· newest 2013-12-31
Total liabilities: 5 of 11 periods available· newest 2013-12-31
Current assets: 10 of 11 periods available· newest 2013-12-31
Current liabilities: 10 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2013-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2013-12-31
Shares outstanding: 3 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+56.9%

Prior period

USD 509.29 million

2012-01-01 – 2012-12-31
Current period

USD 798.93 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

798929000 − 509292000 = 289637000 USD

509292000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
798929000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Year-over-year change in Revenue: 289637000 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 798929000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#1128040 Filing: 000125582314000005 Input fundies:Revenue: 509292000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#1127881 Filing: 000125582314000005
The citation records this snapshot. The page link may show a newer release later.
Net income
+48%

Prior period

USD 197.68 million

2012-01-01 – 2012-12-31
Current period

USD 292.61 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

292609000 − 197675000 = 94934000 USD

197675000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
292609000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Year-over-year change in Net income: 94934000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 292609000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662854 Filing: 000125582314000005 Input fundies:NetIncome: 197675000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662699 Filing: 000125582314000005
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+54.2%

Prior period

USD 219.04 million

2012-01-01 – 2012-12-31
Current period

USD 337.78 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

337778000 − 219037000 = 118741000 USD

219037000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
337778000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Year-over-year change in Operating cash flow: 118741000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 337778000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662119 Filing: 000125582314000005 Input fundies:OperatingCashFlow: 219037000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662332 Filing: 000125582314000005
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+232%

Prior period

USD 1.07 million

2012-01-01 – 2012-12-31
Current period

USD 3.54 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

3536000 − 1065000 = 2471000 USD

1065000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
3536000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Year-over-year change in Capital expenditure: 2471000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3536000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000021/qcor-20140630.xml#432388 Filing: 000125582314000021 Input fundies:CapitalExpenditure: 1065000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#982131 Filing: 000125582314000005
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

Revenue USD 798.93 million 100% of revenue
Cost of revenue USD 74.37 million 9.3% of revenue
Operating expenses USD 284.73 million 36% of revenue
Operating income USD 439.84 million 55% of revenue
Tax, interest and other Derived USD 147.23 million 18% of revenue
Net income USD 292.61 million 37% of revenue

Cash

Operating cash flow USD 337.78 million 42% of revenue
Capital expenditure USD 3.54 million 0.4% of revenue
Free cash flow Derived USD 334.24 million 42% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Operating loss: operating costs were 124% of revenue.
2004 Operating loss: operating costs were 101% of revenue.
2005 Operating loss: operating costs were 115% of revenue.
2006 Operating loss: operating costs were 185% of revenue.
2007 Net income was higher than operating income, so the split is not drawn.
2008 43%18%40%
2010 30%16%53%
2011 36%15%48%
2012 39%19%42%
2013 37%18%45%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2003-01-01 – 2003-12-31	14063000	17397000 Derived	-3334000	457000 Derived	-3791000	-3680000 Derived	Source 2003-01-01 – 2003-12-31: 14063000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -3334000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -3791000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -3346000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 334000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	18404000	18670000 Derived	-266000	566000 Derived	-832000	1538000 Derived	Source 2004-01-01 – 2004-12-31: 18404000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -266000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -832000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 1758000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 220000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	14162000	16351000 Derived	-2189000	-9581000 Derived	7392000	1126000 Derived	Source 2005-01-01 – 2005-12-31: 14162000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -2189000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 7392000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 1367000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 241000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	12788000	23631000 Derived	-10843000	-734000 Derived	-10109000	-9933000 Derived	Source 2006-01-01 – 2006-12-31: 12788000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -10843000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -10109000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -9728000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 205000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	49768000	28213000 Derived	21555000	-16031000 Derived	37586000	9997000 Derived	Source 2007-01-01 – 2007-12-31: 49768000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 21555000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 37586000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 10066000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 69000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	95248000	37668000 Derived	57580000	17048000 Derived	40532000	63376000 Derived	Source 2008-01-01 – 2008-12-31: 95248000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 57580000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 40532000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 63509000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 133000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	115131000	61291000 Derived	53840000	18769000 Derived	35071000	35844000 Derived	Source 2010-01-01 – 2010-12-31: 115131000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 53840000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 35071000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 36557000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 713000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	218169000	105051000 Derived	113118000	33527000 Derived	79591000	83776000 Derived	Source 2011-01-01 – 2011-12-31: 218169000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 113118000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 79591000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 85599000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 1823000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	509292000	212765000 Derived	296527000	98852000 Derived	197675000	217972000 Derived	Source 2012-01-01 – 2012-12-31: 509292000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 296527000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 197675000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 219037000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 1065000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	798929000	359091000 Derived	439838000	147229000 Derived	292609000	334242000 Derived	Source 2013-01-01 – 2013-12-31: 798929000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 439838000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 292609000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 337778000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 3536000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 798.9M 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Revenue	14063000	Revenue: 14063000 Open source
20042004-12-31	Revenue	18404000	Revenue: 18404000 Open source
20052005-12-31	Revenue	14162000	Revenue: 14162000 Open source
20062006-12-31	Revenue	12788000	Revenue: 12788000 Open source
20072007-12-31	Revenue	49768000	Revenue: 49768000 Open source
20082008-12-31	Revenue	95248000	Revenue: 95248000 Open source
20102010-12-31	Revenue	115131000	Revenue: 115131000 Open source
20112011-12-31	Revenue	218169000	Revenue: 218169000 Open source
20122012-12-31	Revenue	509292000	Revenue: 509292000 Open source
20132013-12-31	Revenue	798929000	Revenue: 798929000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

56.9% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Year over year	No prior comparable period	Revenue: 14063000 Open source
20042004-12-31	Year over year	30.9%	Revenue: 18404000 Open source Revenue: 14063000 Open source
20052005-12-31	Year over year	-23%	Revenue: 14162000 Open source Revenue: 18404000 Open source
20062006-12-31	Year over year	-9.7%	Revenue: 12788000 Open source Revenue: 14162000 Open source
20072007-12-31	Year over year	289.2%	Revenue: 49768000 Open source Revenue: 12788000 Open source
20082008-12-31	Year over year	91.4%	Revenue: 95248000 Open source Revenue: 49768000 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 115131000 Open source
20112011-12-31	Year over year	89.5%	Revenue: 218169000 Open source Revenue: 115131000 Open source
20122012-12-31	Year over year	133.4%	Revenue: 509292000 Open source Revenue: 218169000 Open source
20132013-12-31	Year over year	56.9%	Revenue: 798929000 Open source Revenue: 509292000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 55.1% 2013

Net margin 36.6% 2013

Free cash flow margin 41.8% 2013

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Operating margin	-23.7%	Operating Income: -3334000 Open source Revenue: 14063000 Open source
20042004-12-31	Operating margin	-1.4%	Operating Income: -266000 Open source Revenue: 18404000 Open source
20052005-12-31	Operating margin	-15.5%	Operating Income: -2189000 Open source Revenue: 14162000 Open source
20062006-12-31	Operating margin	-84.8%	Operating Income: -10843000 Open source Revenue: 12788000 Open source
20072007-12-31	Operating margin	43.3%	Operating Income: 21555000 Open source Revenue: 49768000 Open source
20082008-12-31	Operating margin	60.5%	Operating Income: 57580000 Open source Revenue: 95248000 Open source
20102010-12-31	Operating margin	46.8%	Operating Income: 53840000 Open source Revenue: 115131000 Open source
20112011-12-31	Operating margin	51.8%	Operating Income: 113118000 Open source Revenue: 218169000 Open source
20122012-12-31	Operating margin	58.2%	Operating Income: 296527000 Open source Revenue: 509292000 Open source
20132013-12-31	Operating margin	55.1%	Operating Income: 439838000 Open source Revenue: 798929000 Open source
20032003-12-31	Net margin	-27%	Net Income: -3791000 Open source Revenue: 14063000 Open source
20042004-12-31	Net margin	-4.5%	Net Income: -832000 Open source Revenue: 18404000 Open source
20052005-12-31	Net margin	52.2%	Net Income: 7392000 Open source Revenue: 14162000 Open source
20062006-12-31	Net margin	-79.1%	Net Income: -10109000 Open source Revenue: 12788000 Open source
20072007-12-31	Net margin	75.5%	Net Income: 37586000 Open source Revenue: 49768000 Open source
20082008-12-31	Net margin	42.6%	Net Income: 40532000 Open source Revenue: 95248000 Open source
20102010-12-31	Net margin	30.5%	Net Income: 35071000 Open source Revenue: 115131000 Open source
20112011-12-31	Net margin	36.5%	Net Income: 79591000 Open source Revenue: 218169000 Open source
20122012-12-31	Net margin	38.8%	Net Income: 197675000 Open source Revenue: 509292000 Open source
20132013-12-31	Net margin	36.6%	Net Income: 292609000 Open source Revenue: 798929000 Open source
20032003-12-31	Free cash flow margin	-26.2%	Revenue: 14063000 Open source Operating Cash Flow: -3346000 Open source Capital Expenditure: 334000 Open source
20042004-12-31	Free cash flow margin	8.4%	Revenue: 18404000 Open source Operating Cash Flow: 1758000 Open source Capital Expenditure: 220000 Open source
20052005-12-31	Free cash flow margin	8%	Revenue: 14162000 Open source Operating Cash Flow: 1367000 Open source Capital Expenditure: 241000 Open source
20062006-12-31	Free cash flow margin	-77.7%	Revenue: 12788000 Open source Operating Cash Flow: -9728000 Open source Capital Expenditure: 205000 Open source
20072007-12-31	Free cash flow margin	20.1%	Revenue: 49768000 Open source Operating Cash Flow: 10066000 Open source Capital Expenditure: 69000 Open source
20082008-12-31	Free cash flow margin	66.5%	Revenue: 95248000 Open source Operating Cash Flow: 63509000 Open source Capital Expenditure: 133000 Open source
20102010-12-31	Free cash flow margin	31.1%	Revenue: 115131000 Open source Operating Cash Flow: 36557000 Open source Capital Expenditure: 713000 Open source
20112011-12-31	Free cash flow margin	38.4%	Revenue: 218169000 Open source Operating Cash Flow: 85599000 Open source Capital Expenditure: 1823000 Open source
20122012-12-31	Free cash flow margin	42.8%	Revenue: 509292000 Open source Operating Cash Flow: 219037000 Open source Capital Expenditure: 1065000 Open source
20132013-12-31	Free cash flow margin	41.8%	Revenue: 798929000 Open source Operating Cash Flow: 337778000 Open source Capital Expenditure: 3536000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 337.8M 2013

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Operating cash flow	-3346000	Operating Cash Flow: -3346000 Open source
20042004-12-31	Operating cash flow	1758000	Operating Cash Flow: 1758000 Open source
20052005-12-31	Operating cash flow	1367000	Operating Cash Flow: 1367000 Open source
20062006-12-31	Operating cash flow	-9728000	Operating Cash Flow: -9728000 Open source
20072007-12-31	Operating cash flow	10066000	Operating Cash Flow: 10066000 Open source
20082008-12-31	Operating cash flow	63509000	Operating Cash Flow: 63509000 Open source
20102010-12-31	Operating cash flow	36557000	Operating Cash Flow: 36557000 Open source
20112011-12-31	Operating cash flow	85599000	Operating Cash Flow: 85599000 Open source
20122012-12-31	Operating cash flow	219037000	Operating Cash Flow: 219037000 Open source
20132013-12-31	Operating cash flow	337778000	Operating Cash Flow: 337778000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 334.2M 2013

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Free cash flow	-3680000	Operating Cash Flow: -3346000 Open source Capital Expenditure: 334000 Open source
20042004-12-31	Free cash flow	1538000	Operating Cash Flow: 1758000 Open source Capital Expenditure: 220000 Open source
20052005-12-31	Free cash flow	1126000	Operating Cash Flow: 1367000 Open source Capital Expenditure: 241000 Open source
20062006-12-31	Free cash flow	-9933000	Operating Cash Flow: -9728000 Open source Capital Expenditure: 205000 Open source
20072007-12-31	Free cash flow	9997000	Operating Cash Flow: 10066000 Open source Capital Expenditure: 69000 Open source
20082008-12-31	Free cash flow	63376000	Operating Cash Flow: 63509000 Open source Capital Expenditure: 133000 Open source
20102010-12-31	Free cash flow	35844000	Operating Cash Flow: 36557000 Open source Capital Expenditure: 713000 Open source
20112011-12-31	Free cash flow	83776000	Operating Cash Flow: 85599000 Open source Capital Expenditure: 1823000 Open source
20122012-12-31	Free cash flow	217972000	Operating Cash Flow: 219037000 Open source Capital Expenditure: 1065000 Open source
20132013-12-31	Free cash flow	334242000	Operating Cash Flow: 337778000 Open source Capital Expenditure: 3536000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

45.8% 2013

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Liabilities / assets	Not reported	Total Assets: 22929000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 28173000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 31348000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 29635000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 78448000 Open source
20082008-12-31	Liabilities / assets	23.8%	Total Liabilities: 21254000 Open source Total Assets: 89146000 Open source
2010-12-31	Liabilities / assets	Not reported	No source recorded
20112011-12-31	Liabilities / assets	20.3%	Total Liabilities: 55982000 Open source Total Assets: 275808000 Open source
20122012-12-31	Liabilities / assets	35.9%	Total Liabilities: 90602000 Open source Total Assets: 252431000 Open source
20132013-12-31	Liabilities / assets	45.8%	Total Liabilities: 336990000 Open source Total Assets: 736354000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.47× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Current assets / current liabilities	2.47×	Current Assets: 7304000 Open source Current Liabilities: 2952000 Open source
20042004-12-31	Current assets / current liabilities	1.59×	Current Assets: 13686000 Open source Current Liabilities: 8604000 Open source
20052005-12-31	Current assets / current liabilities	2.2×	Current Assets: 29589000 Open source Current Liabilities: 13468000 Open source
20062006-12-31	Current assets / current liabilities	3.7×	Current Assets: 23984000 Open source Current Liabilities: 6478000 Open source
20072007-12-31	Current assets / current liabilities	4.88×	Current Assets: 71873000 Open source Current Liabilities: 14720000 Open source
20082008-12-31	Current assets / current liabilities	4×	Current Assets: 78997000 Open source Current Liabilities: 19725000 Open source
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
20112011-12-31	Current assets / current liabilities	4.77×	Current Assets: 265600000 Open source Current Liabilities: 55721000 Open source
20122012-12-31	Current assets / current liabilities	2.62×	Current Assets: 237276000 Open source Current Liabilities: 90399000 Open source
20132013-12-31	Current assets / current liabilities	2.47×	Current Assets: 396776000 Open source Current Liabilities: 160570000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2003-01-01 – 2003-12-31	−USD 3.79 million Exact value Exact value: -3791000 USD 2003-01-01 – 2003-12-31: -3791000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2003-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: -3791000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3791000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-06-006290.txt#29300 The citation records this snapshot. The page link may show a newer release later.	−USD 3.35 million Exact value Exact value: -3346000 USD 2003-01-01 – 2003-12-31: -3346000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2003-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: -3346000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3346000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-06-006290.txt#30093 The citation records this snapshot. The page link may show a newer release later.	USD 334,000 Exact value Exact value: 334000 USD 2003-01-01 – 2003-12-31: 334000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2003-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 334000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 334000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-06-006290.txt#30315 The citation records this snapshot. The page link may show a newer release later.	−USD 3.68 million Calculation and evidence -3346000 − 334000 USD Exact free cash flow: -3680000 USD 2003-01-01 – 2003-12-31: -3346000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 334000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2003-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: -3680000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3346000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-06-006290.txt#30093 Input fundies:CapitalExpenditure: 334000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-06-006290.txt#30315 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 832,000 Exact value Exact value: -832000 USD 2004-01-01 – 2004-12-31: -832000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2004-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: -832000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -832000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-07-006944.txt#29971 The citation records this snapshot. The page link may show a newer release later.	USD 1.76 million Exact value Exact value: 1758000 USD 2004-01-01 – 2004-12-31: 1758000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2004-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 1758000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1758000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-07-006944.txt#30764 The citation records this snapshot. The page link may show a newer release later.	USD 220,000 Exact value Exact value: 220000 USD 2004-01-01 – 2004-12-31: 220000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2004-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 220000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 220000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-07-006944.txt#31027 The citation records this snapshot. The page link may show a newer release later.	USD 1.54 million Calculation and evidence 1758000 − 220000 USD Exact free cash flow: 1538000 USD 2004-01-01 – 2004-12-31: 1758000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 220000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2004-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 1538000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1758000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-07-006944.txt#30764 Input fundies:CapitalExpenditure: 220000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-07-006944.txt#31027 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 7.39 million Exact value Exact value: 7392000 USD 2005-01-01 – 2005-12-31: 7392000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2005-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: 7392000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7392000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000891618-08-000171.txt#30990 The citation records this snapshot. The page link may show a newer release later.	USD 1.37 million Exact value Exact value: 1367000 USD 2005-01-01 – 2005-12-31: 1367000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2005-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 1367000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1367000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000891618-08-000171.txt#31892 The citation records this snapshot. The page link may show a newer release later.	USD 241,000 Exact value Exact value: 241000 USD 2005-01-01 – 2005-12-31: 241000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2005-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 241000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 241000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000891618-08-000171.txt#32148 The citation records this snapshot. The page link may show a newer release later.	USD 1.13 million Calculation and evidence 1367000 − 241000 USD Exact free cash flow: 1126000 USD 2005-01-01 – 2005-12-31: 1367000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 241000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2005-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 1126000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1367000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000891618-08-000171.txt#31892 Input fundies:CapitalExpenditure: 241000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000891618-08-000171.txt#32148 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 10.11 million Exact value Exact value: -10109000 USD 2006-01-01 – 2006-12-31: -10109000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2006-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: -10109000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10109000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-09-005448.txt#30434 The citation records this snapshot. The page link may show a newer release later.	−USD 9.73 million Exact value Exact value: -9728000 USD 2006-01-01 – 2006-12-31: -9728000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2006-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: -9728000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9728000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-09-005448.txt#31422 The citation records this snapshot. The page link may show a newer release later.	USD 205,000 Exact value Exact value: 205000 USD 2006-01-01 – 2006-12-31: 205000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2006-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 205000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 205000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-09-005448.txt#31678 The citation records this snapshot. The page link may show a newer release later.	−USD 9.93 million Calculation and evidence -9728000 − 205000 USD Exact free cash flow: -9933000 USD 2006-01-01 – 2006-12-31: -9728000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 205000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2006-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: -9933000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9728000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-09-005448.txt#31422 Input fundies:CapitalExpenditure: 205000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950134-09-005448.txt#31678 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 37.59 million Exact value Exact value: 37586000 USD 2007-01-01 – 2007-12-31: 37586000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2007-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: 37586000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 37586000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950123-10-024927.txt#31301 The citation records this snapshot. The page link may show a newer release later.	USD 10.07 million Exact value Exact value: 10066000 USD 2007-01-01 – 2007-12-31: 10066000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2007-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 10066000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10066000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950123-10-024927.txt#32246 The citation records this snapshot. The page link may show a newer release later.	USD 69,000 Exact value Exact value: 69000 USD 2007-01-01 – 2007-12-31: 69000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2007-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 69000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 69000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950123-10-024927.txt#32502 The citation records this snapshot. The page link may show a newer release later.	USD 10 million Calculation and evidence 10066000 − 69000 USD Exact free cash flow: 9997000 USD 2007-01-01 – 2007-12-31: 10066000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 69000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2007-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 9997000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10066000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950123-10-024927.txt#32246 Input fundies:CapitalExpenditure: 69000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0000950123-10-024927.txt#32502 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 40.53 million Exact value Exact value: 40532000 USD 2008-01-01 – 2008-12-31: 40532000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2008-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: 40532000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 40532000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0001193125-11-043600.txt#6799 The citation records this snapshot. The page link may show a newer release later.	USD 63.51 million Exact value Exact value: 63509000 USD 2008-01-01 – 2008-12-31: 63509000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2008-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 63509000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 63509000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0001193125-11-043600.txt#7079 The citation records this snapshot. The page link may show a newer release later.	USD 133,000 Exact value Exact value: 133000 USD 2008-01-01 – 2008-12-31: 133000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2008-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 133000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 133000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0001193125-11-043600.txt#7149 The citation records this snapshot. The page link may show a newer release later.	USD 63.38 million Calculation and evidence 63509000 − 133000 USD Exact free cash flow: 63376000 USD 2008-01-01 – 2008-12-31: 63509000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 133000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2008-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 63376000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 63509000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0001193125-11-043600.txt#7079 Input fundies:CapitalExpenditure: 133000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/0001193125-11-043600.txt#7149 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 35.07 million Exact value Exact value: 35071000 USD 2010-01-01 – 2010-12-31: 35071000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2010-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: 35071000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 35071000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000150237513000004/qcor-20121231.xml#473468 Filing: 000150237513000004 The citation records this snapshot. The page link may show a newer release later.	USD 36.56 million Exact value Exact value: 36557000 USD 2010-01-01 – 2010-12-31: 36557000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2010-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 36557000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 36557000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000150237513000004/qcor-20121231.xml#473109 Filing: 000150237513000004 The citation records this snapshot. The page link may show a newer release later.	USD 713,000 Exact value Exact value: 713000 USD 2010-01-01 – 2010-12-31: 713000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2010-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 713000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 713000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000150237513000004/qcor-20121231.xml#754828 Filing: 000150237513000004 The citation records this snapshot. The page link may show a newer release later.	USD 35.84 million Calculation and evidence 36557000 − 713000 USD Exact free cash flow: 35844000 USD 2010-01-01 – 2010-12-31: 36557000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 713000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2010-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 35844000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 36557000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000150237513000004/qcor-20121231.xml#473109 Filing: 000150237513000004 Input fundies:CapitalExpenditure: 713000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000150237513000004/qcor-20121231.xml#754828 Filing: 000150237513000004 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 79.59 million Exact value Exact value: 79591000 USD 2011-01-01 – 2011-12-31: 79591000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2011-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: 79591000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 79591000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662545 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 85.6 million Exact value Exact value: 85599000 USD 2011-01-01 – 2011-12-31: 85599000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2011-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 85599000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 85599000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#661907 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 1.82 million Exact value Exact value: 1823000 USD 2011-01-01 – 2011-12-31: 1823000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2011-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 1823000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1823000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#981920 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 83.78 million Calculation and evidence 85599000 − 1823000 USD Exact free cash flow: 83776000 USD 2011-01-01 – 2011-12-31: 85599000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 1823000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2011-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 83776000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 85599000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#661907 Filing: 000125582314000005 Input fundies:CapitalExpenditure: 1823000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#981920 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	USD 197.68 million Exact value Exact value: 197675000 USD 2012-01-01 – 2012-12-31: 197675000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2012-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: 197675000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 197675000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662699 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 219.04 million Exact value Exact value: 219037000 USD 2012-01-01 – 2012-12-31: 219037000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2012-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 219037000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 219037000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662332 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 1.07 million Exact value Exact value: 1065000 USD 2012-01-01 – 2012-12-31: 1065000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2012-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 1065000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1065000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#982131 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 217.97 million Calculation and evidence 219037000 − 1065000 USD Exact free cash flow: 217972000 USD 2012-01-01 – 2012-12-31: 219037000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 1065000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2012-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 217972000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 219037000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662332 Filing: 000125582314000005 Input fundies:CapitalExpenditure: 1065000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#982131 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 292.61 million Exact value Exact value: 292609000 USD 2013-01-01 – 2013-12-31: 292609000 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Net Income: 292609000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 292609000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662854 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 337.78 million Exact value Exact value: 337778000 USD 2013-01-01 – 2013-12-31: 337778000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Operating Cash Flow: 337778000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 337778000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662119 Filing: 000125582314000005 The citation records this snapshot. The page link may show a newer release later.	USD 3.54 million Exact value Exact value: 3536000 USD 2013-01-01 – 2013-12-31: 3536000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Capital Expenditure: 3536000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3536000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000021/qcor-20140630.xml#432388 Filing: 000125582314000021 The citation records this snapshot. The page link may show a newer release later.	USD 334.24 million Calculation and evidence 337778000 − 3536000 USD Exact free cash flow: 334242000 USD 2013-01-01 – 2013-12-31: 337778000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 3536000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · QUESTCOR PHARMACEUTICALS INC · 2013-12-31 QUESTCOR PHARMACEUTICALS INC (edgar:891288) Free cash flow: 334242000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/891288?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 337778000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000005/qcor-20131231.xml#662119 Filing: 000125582314000005 Input fundies:CapitalExpenditure: 3536000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/891288/000125582314000021/qcor-20140630.xml#432388 Filing: 000125582314000021 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

95 filings · 1,915 latest values · 1,915 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000891288, 891288, edgar:891288

Also known as CYPROS PHARMACEUTICAL CORP, QUESTCOR PHARMACEUTICALS INC

QUESTCOR PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2013 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation